Predictive Oncology Announces Plan to Offer 1.92M Shares POAI Stock News
POAI Stock | USD 0.76 0.01 1.29% |
Under 50% of Predictive Oncology's traders are presently thinking to get in. The analysis of overall sentiment of trading Predictive Oncology stock suggests that some investors are interested at this time. Predictive Oncology's investing sentiment shows overall attitude of investors towards Predictive Oncology.
Predictive | Build AI portfolio with Predictive Stock |
Predictive Oncology, under the ticker POAI, has declared its intention to sell 1.92 million shares of common stock. This move involves offering shares held by c
Read at gurufocus.com
![]() |
Predictive Oncology Current Investor Sentiment
Comfort Level 50
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Predictive Oncology's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Predictive Oncology.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentAcquiring |
Predictive Oncology Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Predictive Oncology can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Predictive Oncology Historical Investor Sentiment
Investor biases related to Predictive Oncology's public news can be used to forecast risks associated with an investment in Predictive. The trend in average sentiment can be used to explain how an investor holding Predictive can time the market purely based on public headlines and social activities around Predictive Oncology. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Predictive Oncology's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Predictive Oncology and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Predictive Oncology news discussions. The higher the estimate score, the more favorable the investor's outlook on Predictive Oncology.
Predictive Oncology Fundamental Analysis
We analyze Predictive Oncology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Predictive Oncology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Predictive Oncology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Predictive Oncology is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Predictive Oncology Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Predictive Oncology stock to make a market-neutral strategy. Peer analysis of Predictive Oncology could also be used in its relative valuation, which is a method of valuing Predictive Oncology by comparing valuation metrics with similar companies.
Peers
Predictive Oncology Related Equities
MBOT | Microbot Medical | 4.53 | ||||
NAOV | NanoVibronix | 0.27 | ||||
LUCY | Innovative Eyewear | 0.50 | ||||
GCTK | GlucoTrack | 0.50 | ||||
PHIO | Phio Pharmaceuticals | 0.84 | ||||
STSS | Sharps Technology | 1.95 | ||||
SLRX | Salarius Pharmaceuticals | 3.17 | ||||
MHUA | Meihua International | 5.26 |
Complementary Tools for Predictive Stock analysis
When running Predictive Oncology's price analysis, check to measure Predictive Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Predictive Oncology is operating at the current time. Most of Predictive Oncology's value examination focuses on studying past and present price action to predict the probability of Predictive Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Predictive Oncology's price. Additionally, you may evaluate how the addition of Predictive Oncology to your portfolios can decrease your overall portfolio volatility.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Transaction History View history of all your transactions and understand their impact on performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |